Table: Daito -Q1 group results

Daito Pharmaceutical

11/10/2019 07:00

Oct 11 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2019        Aug 31, 2018     May 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             11.66               9.74             43.50    
                 (+19.7 pct)         (+0.6 pct)       (+5.7 pct)  
  Operating          1.36               1.09              4.70    
                 (+24.0 pct)         (+17.4 pct)      (+3.4 pct)  
  Recurring          1.39               1.14              4.75    
                 (+22.0 pct)         (+17.2 pct)      (+2.3 pct)  
  Net              920 mln             779 mln            3.30    
                 (+18.0 pct)         (+15.8 pct)      (-6.1 pct)  
  EPS             73.55 yen           62.32 yen       263.71 yen  
  Ann Div                             38.00 yen        40.00 yen  
  -Q2 div                             18.00 yen        20.00 yen  
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T